Evonik has launched a brand-new podcast dedicated to tackling the sustainability challenges facing the animal protein industry. In monthly episodes, the Sciencing
“As the world population grows and demand for food increases, global solutions are needed to feed future generations healthily, while protecting our planet”, says Gaetano Blanda, head of the Animal Nutrition business line of Evonik. “We are on fire to develop such solutions, and to foster the dialogue within the industry.”
The Nutrition & Care division of Evonik, to which the Animal Nutrition business line belongs, has made sustainability its leading business principle.
Listeners to the podcast will receive cutting-edge insights on the science of sustainability, the solutions needed to make animal nutrition and protein production more sustainable and why, ultimately, it makes good business sense.
“We’re really excited to be launching The Sciencing Podcast, which will be drilling down into the critical topic of how we can innovate and collaborate to improve environmental impacts in the animal protein sector”, says Faazi.
“Ensuring sustainable global food production is the greatest challenge we face. It is no understatement to say it affects each and every one of us. That’s why we’re here to ‘science’ it and we invite you to join us on that journey and subscribe to The Sciencing Podcast today.”
Listeners can follow the podcast for free on various platforms such as Amazon Music, Apple Podcasts, and Spotify.
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.38 billion in 2021. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.
The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €3.56 billion in 2021 with about 5,300 employees.


Be the first to comment